Paul M. Hinderliter

2.5k total citations · 1 hit paper
36 papers, 1.9k citations indexed

About

Paul M. Hinderliter is a scholar working on Health, Toxicology and Mutagenesis, Plant Science and Cancer Research. According to data from OpenAlex, Paul M. Hinderliter has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Health, Toxicology and Mutagenesis, 9 papers in Plant Science and 9 papers in Cancer Research. Recurrent topics in Paul M. Hinderliter's work include Carcinogens and Genotoxicity Assessment (9 papers), Pesticide Exposure and Toxicity (9 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Paul M. Hinderliter is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), Pesticide Exposure and Toxicity (9 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Paul M. Hinderliter collaborates with scholars based in United States, United Kingdom and Switzerland. Paul M. Hinderliter's co-authors include Justin Teeguarden, Joel G. Pounds, Brian D. Thrall, Galya Orr, Kevin R. Minard, William Chrisler, Gerald L. Kennedy, William J. Fasano, Shawn A. Gannon and Timothy Arthur Chandos Snow and has published in prestigious journals such as Food and Chemical Toxicology, Toxicology and Applied Pharmacology and Toxicological Sciences.

In The Last Decade

Paul M. Hinderliter

36 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Particokinetics In Vitro: Dosimetry Considerations for In Vitro Nanoparticle Toxicity Assessments

2006 608 citations Justin Teeguarden, Paul M. Hinderliter et al. Toxicological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul M. Hinderliter United States	21	701	695	399	319	263	36	1.9k
Elke Dopp Germany	25	759 1.1×	662 1.0×	255 0.6×	313 1.0×	114 0.4×	57	2.2k
Jung‐Taek Kwon South Korea	25	351 0.5×	493 0.7×	290 0.7×	65 0.2×	219 0.8×	79	2.1k
Norihiro Kobayashi Japan	22	450 0.6×	982 1.4×	509 1.3×	52 0.2×	134 0.5×	52	1.6k
M. Stępnik Poland	19	357 0.5×	364 0.5×	153 0.4×	143 0.4×	82 0.3×	79	1.2k
Barbara Gouget France	22	376 0.5×	836 1.2×	389 1.0×	61 0.2×	100 0.4×	49	2.2k
Makoto Ema Japan	24	745 1.1×	918 1.3×	522 1.3×	47 0.1×	108 0.4×	74	2.0k
Josje H.E. Arts Netherlands	26	848 1.2×	495 0.7×	303 0.8×	59 0.2×	53 0.2×	71	2.1k
Xinyuan Zhao China	27	356 0.5×	852 1.2×	808 2.0×	102 0.3×	166 0.6×	146	2.8k
Yuko Ibuki Japan	28	455 0.6×	642 0.9×	330 0.8×	58 0.2×	164 0.6×	102	2.3k
Tiancheng Wang China	23	960 1.4×	1.3k 1.9×	694 1.7×	37 0.1×	285 1.1×	79	2.8k

Countries citing papers authored by Paul M. Hinderliter

Since Specialization

Citations

This map shows the geographic impact of Paul M. Hinderliter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Hinderliter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Hinderliter more than expected).

Fields of papers citing papers by Paul M. Hinderliter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Hinderliter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Hinderliter. The network helps show where Paul M. Hinderliter may publish in the future.

Co-authorship network of co-authors of Paul M. Hinderliter

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Hinderliter. A scholar is included among the top collaborators of Paul M. Hinderliter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Hinderliter. Paul M. Hinderliter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campbell, Jerry L., Kim Z. Travis, Harvey J. Clewell, et al.. (2021). Integration of paraquat pharmacokinetic data across species using PBPK modelling. Toxicology and Applied Pharmacology. 417. 115462–115462. 5 indexed citations

Stevens, Alexander J., Jerry L. Campbell, Kim Z. Travis, et al.. (2021). Paraquat pharmacokinetics in primates and extrapolation to humans. Toxicology and Applied Pharmacology. 417. 115463–115463. 14 indexed citations

McGee, Marie, Lei Li, Samuel Constant, et al.. (2021). Use of the MucilAir Airway Assay, a New Approach Methodology, for Evaluating the Safety and Inhalation Risk of Agrochemicals. 7(2). 50–60. 18 indexed citations

Tan, Yu‐Mei, Amechi C. Chukwudebe, Jeanne Y. Domoradzki, et al.. (2020). PBPK model reporting template for chemical risk assessment applications. Regulatory Toxicology and Pharmacology. 115. 104691–104691. 45 indexed citations

Clippinger, Amy J., David Allen, Holger Behrsing, et al.. (2018). Nonanimal Approaches to Assessing the Toxicity of Inhaled Substances: Current Progress and Future Promise. 4(2). 82–88. 3 indexed citations

Campbell, Jerry L., Melvin E. Andersen, Paul M. Hinderliter, et al.. (2016). PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human. Toxicological Sciences. 150(2). 441–453. 25 indexed citations

Smith, Jordan N., Paul M. Hinderliter, Charles Timchalk, Michael Bartels, & Torka S. Poet. (2013). A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: Development and validation. Regulatory Toxicology and Pharmacology. 69(3). 580–597. 21 indexed citations

Price, Paul S., Cheryl B. Cleveland, Michael Bartels, et al.. (2011). Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues. Regulatory Toxicology and Pharmacology. 61(1). 23–31. 14 indexed citations

Hinderliter, Paul M., Kevin R. Minard, Galya Orr, et al.. (2010). ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Particle and Fibre Toxicology. 7(1). 36–36. 384 indexed citations

10.

Poet, Torka S., et al.. (2010). Hydroquinone PBPK model refinement and application to dermal exposure. Food and Chemical Toxicology. 48(11). 3085–3092. 6 indexed citations

11.

Poet, Torka S., et al.. (2009). Quantitative Risk Analysis for N-Methyl Pyrrolidone Using Physiologically Based Pharmacokinetic and Benchmark Dose Modeling. Toxicological Sciences. 113(2). 468–482. 30 indexed citations

12.

Fasano, William J., Shawn A. Gannon, Timothy Arthur Chandos Snow, et al.. (2008). Absorption, Distribution, Metabolism, and Elimination of 8-2 Fluorotelomer Alcohol in the Rat. Toxicological Sciences. 102(2). 455–455. 4 indexed citations

13.

Gordon, Christopher J., P.J. Spencer, Jon A. Hotchkiss, et al.. (2007). Thermoregulation and its influence on toxicity assessment. Toxicology. 244(2-3). 87–97. 42 indexed citations

14.

Hinderliter, Paul M., Xiaonan Han, Gerald L. Kennedy, & John L. Butenhoff. (2006). Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO). Toxicology. 225(2-3). 195–203. 21 indexed citations

15.

Hinderliter, Paul M., Karla D. Thrall, Richard Corley, Louis Bloemen, & Matthew S. Bogdanffy. (2005). Validation of Human Physiologically Based Pharmacokinetic Model for Vinyl Acetate Against Human Nasal Dosimetry Data. Toxicological Sciences. 85(1). 460–467. 10 indexed citations

16.

Hinderliter, Paul M., Eve Mylchreest, Shawn A. Gannon, John L. Butenhoff, & Gerald L. Kennedy. (2005). Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. Toxicology. 211(1-2). 139–148. 73 indexed citations

17.

Fasano, William J., Gerald L. Kennedy, Bogdan Szostek, et al.. (2005). Penetration of Ammonium Perfluorooctanoate Through Rat and Human Skin In Vitro. Drug and Chemical Toxicology. 28(1). 79–90. 41 indexed citations

18.

Fasano, William J. & Paul M. Hinderliter. (2004). The Tinsley LCR Databridge Model 6401 and electrical impedance measurements to evaluate skin integrity in vitro. Toxicology in Vitro. 18(5). 725–729. 40 indexed citations

19.

Himmelstein, Matthew W., et al.. (2001). The metabolism of β-chloroprene: preliminary in-vitro studies using liver microsomes. Chemico-Biological Interactions. 135-136. 267–284. 16 indexed citations

20.

Betenbaugh, Michael J., Eric Ailor, Erik M. Whiteley, Paul M. Hinderliter, & Tsu‐An Hsu. (1996). Chaperone and foldase coexpression in the baculovirus-insect cell expression system. Cytotechnology. 20(1-3). 149–159. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact